Physical training for McArdle disease
- PMID: 22161416
- DOI: 10.1002/14651858.CD007931.pub2
Physical training for McArdle disease
Abstract
Background: McArdle disease is a rare metabolic myopathy caused by a complete absence of the enzyme muscle glycogen phosphorylase. Affected people experience symptoms of fatigue and cramping within minutes of exercise and are at risk for acute muscle injury (rhabdomyolysis) and acute renal failure. If the first few minutes of exercise are paced, a 'second wind' will occur enabling exercise to continue. This is due to mobilisation and utilisation of alternative fuel substrates. Aerobic training appears to improve work capacity by increasing cardiovascular fitness.
Objectives: To assess the effects of aerobic training in people with McArdle disease.
Search methods: We searched the Cochrane Neuromuscular Disease Group Specialized Register (11 January 2011), CENTRAL (2010, Issue 4), MEDLINE (January 1966 to January 2011) and EMBASE (January 1980 to January 2011).
Selection criteria: All randomised and quasi-randomised controlled studies of aerobic exercise training in people of all ages with McArdle disease.
Data collection and analysis: Two authors identified possible studies for inclusion and assessed their methodological quality. Had more than one study of sufficient methodological quality been identified we would have undertaken a meta-analysis.
Main results: There were no randomised or quasi-randomised controlled trials of aerobic training in people with McArdle disease. However, three open studies using small numbers of participants provided some evidence that aerobic training improves fitness without adverse events in people with McArdle disease.
Authors' conclusions: Evidence from non-randomised studies using small numbers of patients suggest that it would be safe and worthwhile for larger controlled trials of aerobic training to be undertaken in people with McArdle disease.
Similar articles
-
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003458. doi: 10.1002/14651858.CD003458.pub3. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2010 Dec 08;(12):CD003458. doi: 10.1002/14651858.CD003458.pub4. PMID: 18425888 Updated. Review.
-
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).Cochrane Database Syst Rev. 2010 Dec 8;(12):CD003458. doi: 10.1002/14651858.CD003458.pub4. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2014 Nov 12;(11):CD003458. doi: 10.1002/14651858.CD003458.pub5. PMID: 21154353 Updated. Review.
-
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).Cochrane Database Syst Rev. 2014 Nov 12;2014(11):CD003458. doi: 10.1002/14651858.CD003458.pub5. Cochrane Database Syst Rev. 2014. PMID: 25391139 Free PMC article. Review.
-
Strength training and aerobic exercise training for muscle disease.Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003907. doi: 10.1002/14651858.CD003907.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Jul 09;(7):CD003907. doi: 10.1002/14651858.CD003907.pub4. PMID: 20091552 Updated. Review.
-
Strength training and aerobic exercise training for muscle disease.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003907. doi: 10.1002/14651858.CD003907.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003907. doi: 10.1002/14651858.CD003907.pub3. PMID: 15674918 Updated. Review.
Cited by
-
Update on hyperbaric oxygen therapy in burn treatment.Wien Klin Wochenschr. 2021 Feb;133(3-4):137-143. doi: 10.1007/s00508-019-01569-w. Epub 2019 Nov 7. Wien Klin Wochenschr. 2021. PMID: 31701218 Review.
-
Metabolic myopathies.Continuum (Minneap Minn). 2013 Dec;19(6 Muscle Disease):1571-97. doi: 10.1212/01.CON.0000440660.41675.06. Continuum (Minneap Minn). 2013. PMID: 24305448 Free PMC article. Review.
-
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation.Orphanet J Rare Dis. 2023 Jul 25;18(1):210. doi: 10.1186/s13023-023-02825-z. Orphanet J Rare Dis. 2023. PMID: 37488619 Free PMC article.
-
Emotionally-intense situations can result in rhabdomyolysis in McArdle disease.BMJ Case Rep. 2014 Oct 7;2014:bcr2013203272. doi: 10.1136/bcr-2013-203272. BMJ Case Rep. 2014. PMID: 25293680 Free PMC article.
-
Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.J Neuromuscul Dis. 2021;8(3):401-417. doi: 10.3233/JND-200621. J Neuromuscul Dis. 2021. PMID: 33720849 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical